Close Menu

NEW YORK (GenomeWeb) – MDxHealth reported on Thursday that its total revenues for the first nine months of 2017 rose 38 percent, largely due to the sale of its colorectal cancer patents to Exact Sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.